focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,748.50
Bid: 2,175.00
Ask: 1,450.00
Change: -64.00 (-3.53%)
Spread: -725.00 (-33.333%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. STOCKS ON THE MOVE-Silicon Image, Tetraphase, Agenus

Thu, 18th Dec 2014 14:08

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)U.S. stock index futures surged on Thursday, putting the S&P 500on track to extend gains from the prior session, as oil pricesshowed hints of stabilizing and ahead of data on the labormarket. U.S. stock index e-mini futures were up on Thursday: DowJones industrial average futures were up 1.28 percent at17,576, S&P 500 futures were up 1.29 percent at 2,040.25and Nasdaq 100 futures were up 1.40 percent at 4,221.

** SILICON IMAGE INC, Wednesday close $6.74, -24.78pct premarket

The chipmaker said it expects revenue to fall 10 percent in2015 due to fewer mobile design wins from one its largestcustomers.

** TETRAPHASE PHARMACEUTICALS INC, Wednesday close$33.19, +15.40 pct premarket

The drug developer said its antibiotic to treat complicatedintra-abdominal infections was as effective as Merck & Co Inc's ertapenem in a late-stage study.

** DUNKIN' BRANDS GROUP INC, Wednesday close$46.22, -7.38 pct premarket

The Dunkin' Donuts restaurant operator cut its 2015 forecastfor same-store sales growth in the United States and operatingincome growth, citing slowing sales of packaged coffee in itsrestaurants.

** AGENUS INC, Wednesday close $3.35, +14.33 pctpremarket

The biotechnology company said an experimental vaccineagainst shingles by its partner GlaxoSmithKline met itsgoal in a late-stage study. Agenus will get royalties onpotential commercial sales of the vacine.

** JABIL CIRCUIT INC, Wednesday close $20.07, +6.18pct premarket

The company, which makes phone casings for Apple Inc, forecasts second-quarter revenue above estimates,boosted by strong sales of iPhone 6 and 6 Plus. The companyforecast second quarter core earnings of 39-50 cents per share,higher than analysts' average estimate of profit of 38 cents pershare.

** ORACLE INC, Wednesday close $41.16, +6.00 pctpremarket

The software maker reported a 3.5 percent increase inquarterly revenue on Wednesday, beating Wall Street'sexpectations, as sales at its closely watched cloud servicesbusiness rose 45 percent.

** WINNEBAGO INDUSTRIES INC, Wednesday close$23.85, -6.92 pct premarket

The maker of motorhomes and camping trailers reported alower-than-expected profit as a shortage of workers at a keyplant in rural Iowa and trouble sourcing key components fromsuppliers stymied production of the company's recreationalvehicles.

** ACCENTURE PLC, Wednesday close $85.3, +3.17 pctpremarket

The consulting and outsourcing company raised its revenueforecast for fiscal 2015 after contract wins helped the companypost better-than-expected first-quarter earnings and revenue. The company said it expects revenue growth of 5-8 percent forthe year ending August on a local currency basis, up from the4-7 percent growth it had estimated earlier.

** RITE AID CORP, Wednesday close $6.06, +13.37 pctpremarket

The U.S. drugstore chain's quarterly profit jumped 46.5percent as higher sales of prescription drugs boosted same-storesales. The company's net income rose to $104.9 million, or 10cents per share, in the third quarter ended Nov. 29 from $71.6million, or 4 cents per share, a year earlier.

** AK STEEL HOLDING CORP, Wednesday close$5.56, +10.25 pct premarket

The steel maker said it expects fourth-quarter shipments tojump 37 percent compared with the third quarter, helped byacquisitions and strong demand from auto industry.

** THE PANTRY INC, Wednesday close $35.52, +2.25pct premarket

Canadian convenience store operator Alimentation Couche-TardInc will buy the Kangaroo Express chain operator forabout $861 million to boost its presence in the southeastern andGulf Coast regions. Couche-Tard offered $36.75 per share forPantry, which represents a premium of 3.5 percent to the stock'sWednesday close. Including debt, the deal is valued at $1.7billion. Pantry stock jumped 23 percent on Wednesday after theWall Street Journal reported that the company was nearing a dealto sell itself through an auction.

** NATIONAL BANK OF GREECE, Wednesday close$1.99, -4.02 pct premarket

The largest Greek bank's U.S.-listed shares down inpremarket trading on Thursday after first-round presidentialvote in Greece saw Prime Minister Antonis Samaras lose bylarger-than-expected margin.

** BLACKBERRY LTD, Wednesday close $9.98, +1.90 pctpremarket

The Canadian mobile technology company launched itslong-awaited Classic on Wednesday, a smartphone it hopes willhelp it win back market share and woo those still using olderversions of its physical keyboard devices.

** ZAGG INC, Wednesday close $5.33, up 14.4 pctafter market

The mobile accessories maker raised its full-year net salesforecast to $250 million-$255 million from previous range of$225 million-$235 million. The forecast also beat analysts'average estimate of $232.5 million, according to Thomson ReutersI/B/E/S.

** EXXON MOBIL CORP, Wednesday close $89.02, +1.44pct premarket

** CHEVRON CORP, Wednesday close $106.02, +1.80 pctpremarket

** CONOCOPHILLIPS, Wednesday close $66.94, +2.84 pctpremarket

** CHESAPEAKE ENERGY CORP, Wednesday close$18.68, +3.96 pct premarket

Oil company stocks rise after Brent crude jumps 3.3percent to above $63/bbl, extending a rebound from 5-year lowsthis week as more energy firms cut investment in new production.

** HERTZ GLOBAL HOLDINGS INC, Wednesday close$21.31, +4.27 pct premarket

Carl Icahn, the rental car company's largest shareholder,raised stake in the company to 11.34 percent from 10.77 percent.Icahn revealed an 8.48 percent stake in Hertz in August; he hassince ousted CEO Mark Frissora and won three board seats at thecompany.

** KIRBY CORP, Wednesday close $88.75, +0.28 pctpremarket

The tank bank operator lowered fourth quarter earningsestimate to $1.10-$1.20 per share from $1.30-$1.40 per share.The company also lowered its full year earnings estimate to$4.84 to $4.94 per share from $5.04-$5.14 per share. (Compiled by Anannya Pramanick in Bangalore; Edited by DonSebastian)

More News
25 Sep 2023 08:37

TOP NEWS: GSK's Arexvy vaccine approved for adults over 60 in Japan

(Alliance News) - GSK PLC on Monday said the Japan Ministry of Health, Labour & Welfare has approved Arexvy for adults over 60.

Read more
25 Sep 2023 07:28

GSK's RSV vaccine gets approval in Japan

(Sharecast News) - GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for preventing respiratory syncytial virus (RSV) disease in adults aged 60 and over.

Read more
19 Sep 2023 09:30

GSK says new HIV PrEP medication authorised by European Commission

(Alliance News) - GSK PLC on Tuesday said the European Commission has authorised ViiV Healthcare's "superior" drug Apretude to reduce the risk of sexually acquired HIV-1 infection.

Read more
18 Sep 2023 09:40

LONDON BROKER RATINGS: Jefferies likes Energean; JPMorgan raises IDS

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
18 Sep 2023 07:57

LONDON BRIEFING: Phoenix Group hails "impressive" first-half

(Alliance News) - Stocks in London are called lower on Monday, as investors focus on the week's upcoming central bank decisions.

Read more
18 Sep 2023 07:18

US FDA approves GSK treatment for myelofibrosis

(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.

Read more
15 Sep 2023 21:52

GSK's Ojjaara approved in US for myelofibrosis patients with anaemia

(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.

Read more
11 Sep 2023 08:24

Japan accepts GSK's regulatory filing for momelotinib for blood cancer

(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.

Read more
11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

Read more
6 Sep 2023 09:32

LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
4 Sep 2023 06:00

More UK babies to need hospital treatment over delay of GSK's RSV jab

(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.

Read more
1 Sep 2023 09:11

GSK antibody accepted for Japan review, Goldman Sachs reduces stake

(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.

Read more
1 Sep 2023 07:49

LONDON BRIEFING: Stocks seen higher; UK house prices continue to fall

(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.

Read more
1 Sep 2023 07:12

Japan considering GSK's Nucala drug for sinusitis treatment

(Sharecast News) - Japanese regulators are reviewing a new drug application for GSK's Nucala treatment to be used for the treatment of form of adult sinusitis, the biopharma giant announced on Friday.

Read more
23 Aug 2023 12:10

LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data

(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.